SecBot SecBot
Institutional Cluster

FATE

FATE THERAPEUTICS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed12d 14h ago
Institutional cluster: 2 buyers, 3 sellers (mixed)
Actionable Insight • Neutral

The cluster is small in dollar terms and lacks insider corroboration. Monitor next 13F for whether Assenagon's large position was maintained or reversed, and watch for any corporate catalyst (pipeline update, partnership) that could explain the divergence between buyers and sellers.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$2.09
T+0 close · Nov 4, 2026 · via day close
Latest settled
−23.21%
T+5 · $1.61
Vs SPY
−22.29%
α at T+5
Next horizon
T+20
in 16d
  1. T+0 · Nov 4 $2.09entry
  2. T+1 · 12d ago −11.48%α −7.07% · $1.85
  3. T+5 · 6d ago −23.21%α −22.29% · $1.61
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Institutional activity in FATE during Q3 2026 was mixed: two asset managers (Assenagon and Dimensional) added $3.0M in new holdings, while three advisors (Creative Planning, Farther Finance, Wealth Enhancement) trimmed $464K. The net buying is modest relative to the company's $249M market cap, and the 45-day reporting lag means positions may have changed since quarter-end. No insider buying corroborates the institutional moves.

Key Financial Metrics

Direction
mixed
Buy Value
$4.3M
Sell Value
$546.0K
Net Flow
$2.5M

Institutional Positions

Net institutional flow: $2.5M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
Assenagon Asset ManagementDOUBLED+799.5%$3.1M$2.7M
Dimensional Fund AdvisorsADD+46.9%$1.2M$277.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Creative PlanningNEAR_EXIT-79.2%$294.0K-$240.0K
Farther Finance AdvisorsNEAR_EXIT-93.1%$4.0K-$4.0K
Wealth Enhancement Advisory ServicesNEAR_EXIT-85.1%$248.0K-$220.0K

Key Facts

  • 2 buyers added $3.0M in new holdings (Assenagon DOUBLED to $3.1M, Dimensional ADDED to $1.2M)
  • 3 sellers reduced by $464K (Creative Planning, Farther Finance, Wealth Enhancement all near-exit)
  • Net aggregate buying of ~$2.5M, small relative to $249M market cap
  • No open-market insider buying in the window (confluence score 14/100, institutions-only)
  • 13F data is 45+ days stale; positions may have been unwound since quarter-end

Financial Impact

Two asset managers accumulated $3.0M in new positions while three advisors reduced holdings by $464K, for net buying of ~$2.5M

institutional ownershipfloat

Risk Factors

  • 13F data is stale by 45+ days; cluster may have already reversed
  • No insider buying to corroborate the institutional accumulation signal
  • Sellers outnumber buyers 3-to-2, suggesting broader caution among advisors
  • Small dollar amounts relative to market cap limit the signal's significance

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
61% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-FATE-2026-Q3

Track record

21 reports on FATE

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +30.25% at T+5 after the Nov 5, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 13, 20264d ago EFFECT Bearish 5/10 Entry $1.28 settles Nov 20
  2. Nov 12, 20264d ago 424B5 Bearish 4/10 Entry $1.28 settles Nov 20
  3. Nov 9, 20267d ago SC 13D/A Neutral 2/10 Entry $1.77 settles Nov 17
  4. Nov 5, 202611d ago S-3 Neutral 3/10 Entry $1.84 to $1.28 ▼ −30.25% −32.84% vs SPY
  5. Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $1.84 to $1.28 ▲ +30.25% +32.84% vs SPY
  6. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.84 to $1.28 ▲ +30.25% +32.84% vs SPY
  7. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  8. Nov 5, 202611d ago Press Release Neutral 4/10 Entry $1.85 to $1.34 ▼ −27.57% −30.86% vs SPY
  9. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Viewing Entry $2.09 to $1.61 ▼ −23.21% −22.29% vs SPY
  10. Nov 3, 202613d ago 144 Neutral 2/10 Entry $2.04 to $1.77 ▼ −13.24% −12.65% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 8h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026